Hi.

Welcome to my blog. I document my adventures in travel, style, and food. Hope you have a nice stay!

Safety of an extended-release injectable 10% moxidectin suspension 

Safety of an extended-release injectable 10% moxidectin suspension 

The safety of an extended-release injectable suspension of 10% moxidectin was evaluated in four studies using Beagle dogs and one study using ivermectin-sensitive Collies at a recommended dose is 0.5 mg/kg subcutaneously once yearly.

RESULTS: 

In study 1: slight swelling was detectable at some of the  3 and 5 times recommended dose.  

Studies 2 and 3 showed no ill effects identified in reproductive (females) or semen quality characteristics (males). 

Study 4: Showed no adverse effects. 

Study 5: there were no abnormal clinical signs at the recommended dose and also at 3 and 5 times the recommended dose in ivermectin-sensitive dogs.    

Read more by clicking on the link below:

Safety of an extended-release injectable moxidectin suspension formulation in dogs.

Seasonality and prevalence of common canine nematodes in the USA

Seasonality and prevalence of common canine nematodes in the USA

Evaluation of cats post radioiodine therapy

Evaluation of cats post radioiodine therapy